Skip to content
Search

Latest Stories

RPS, GPhC issue joint statement on professional and regulatory standards

All pharmacy owners, pharmacists and technicians are expected to be aware of and use all relevant standards, both regulatory and professional, to support them in their work.

The joint statement published by on Wednesday (June 15) by the Royal Pharmaceutical Society and General Pharmaceutical Council (GPhC) explains the difference between regulatory and professional standards and how they work together to provide a framework for professional practice and patient care.


It states: “All standards set by the GPhC work to improve the quality and safety of services provided to patients and the public. Regulatory standards must be met by all pharmacy professionals and owners of registered pharmacies, otherwise their registration may be at risk.

“Following professional and regulatory standards will help pharmacists, pharmacy technicians and pharmacy owners deliver patient-centred care and good quality outcomes and ensure that members of the public receive safe and effective care.”

The statement also highlighted that while professional standards and guidance are not mandatory, they are developed and owned by the profession and set out what constitutes ‘good’ in terms of practice, systems of care, and working practices.

“Pharmacy professionals following professional standards and guidance set by the RPS should have confidence these help to meet the overarching regulatory standards set by the GPhC,” the two bodies said.

RPS chief executive Paul Bennett commented: “As the professional leadership body for pharmacists, we support our members by providing professional guidance in all areas of practice that challenge and empower them to achieve excellence. Both regulatory and professional standards have the same overarching purpose, to ensure high quality patient care.”

Chief executive of the GPhC Duncan Rudkin added: “As the regulator, we expect all pharmacists, pharmacy technicians and pharmacy owners to be aware of and use all relevant standards, both regulatory and professional, to support them in their work. This helps make sure that patients and the public receive safe and effective care.”

More For You

NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Pharmacy First: Government confirms £215 million boost to realise its full potential

From April 2025, the consultation fee for Pharmacy First Minor Illness and Clinical Pathways will rise from £15 to £17.

‘Pharmacy First hasn't realised its full potential,’ says Stephen Kinnock

Health Minister Stephen Kinnock has acknowledged that Pharmacy First has huge potential, noting that the service “hasn't realised its full potential.”

As part of efforts to enhance the service, Kinnock yesterday (30) announced £215 million in additional funding for Pharmacy First and other Primary Care Access Recovery Plan services.

Keep ReadingShow less
Free morning-after pill at pharmacies to end postcode lottery for patients

Pharmacy technicians will be allowed to supply of drospirenone for contraception under PGD,

gettyimages

Pharmacy contract: Free morning-after pill to be available at pharmacies soon

The UK government has announced that, for the first time ever, the ‘morning-after pill’ or emergency contraceptive pill will be available free of charge at pharmacies on the NHS, ending the postcode lottery women face in accessing the medicine and reducing inequalities.

The Department of Health and Social Care (DHSC) has confirmed a record £3.073 billion funding package for community pharmacies in 2025/26, alongside an additional £215 million to sustain Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less
RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less